Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders.
The Director of Process Chemistry will lead the development of drug substance processes and products for Praxis' small molecule and ASO programs, driving forward clinical and commercial readiness.
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders.
Ardelyx, Inc.